MARINUS PHARMACEUTICALS INC's ticker is MRNS and the CUSIP is 56854Q101. A total of 23 filers reported holding MARINUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $118,000 | +181.0% | 116,511 | +407.5% | 0.00% | – |
| Q3 2016 | $42,000 | +44.8% | 22,956 | 0.0% | 0.00% | – |
| Q2 2016 | $29,000 | -86.5% | 22,956 | -42.6% | 0.00% | – |
| Q1 2016 | $215,000 | -40.1% | 39,959 | -14.9% | 0.00% | – |
| Q4 2015 | $359,000 | +775.6% | 46,972 | +854.9% | 0.00% | – |
| Q3 2015 | $41,000 | +192.9% | 4,919 | +210.0% | 0.00% | – |
| Q1 2015 | $14,000 | – | 1,587 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 1,192,883 | $15,329,000 | 3.00% |
| Bain Capital Life Sciences Investors, LLC | 1,431,059 | $18,389,000 | 1.71% |
| Avoro Capital Advisors LLC | 3,000,000 | $38,550,000 | 0.55% |
| Palo Alto Investors LP | 31,330 | $403,000 | 0.02% |